Below are the best articles we could find on Psychedelic-Assisted Therapy and mdma.
CLEAR ALL
Like most people of color in the United States, psychotherapist and researcher Monnica Williams has experienced myriad forms of racism. Early in her career, understanding its effects on her mind and body motivated her to help clients address their own racial trauma in therapy.
Dr. Joe Tafur and the Modern Spirit Epigenetics Project seek to understand the impact of psychedelics on intergenerational and cultural trauma.
Demand from patients seeking help for their mental illnesses has led to underground use in a way that parallels black markets in the AIDS pandemic. This underground use has been most perilous for people of color, who face greater stigma and legal risks due to the War on Drugs.
A Texas lawmaker introduced a bill on Wednesday that would require the state to study the therapeutic potential of psilocybin, MDMA and ketamine in the treatment of certain mental health conditions.
After decades of demonization and criminalization, psychedelic drugs are on the cusp of entering mainstream psychiatry, with profound implications for a field that in recent decades has seen few pharmacological advancements for the treatment of mental disorders and addiction.
2
“Epigenetic changes will be measured after MDMA-assisted psychotherapy in a first of its kind study,” explains Dr. Joe Tafur about a research collaboration with MAPS investigators, the Modern Spirit research team, and the University of Southern California, Department of Psychiatry.
Supplementing psychotherapy with small doses of MDMA could be an effective strategy to prevent relapses of alcohol addiction in patients, an ongoing small clinical trial suggests.
The drug known by the street names Ecstasy or Molly could be a promising treatment for post-traumatic stress disorder, according to a new study.
Psilocybin, MDMA, and ketamine can lead to a new sense of self and a release from rigid rules for people with anorexia, bulimia, and binge-eating disorder.
The Food and Drug Administration (FDA) has approved the design of two Phase 3 clinical trials of MDMA for treating PTSD, according to the Multidisciplinary Association for Psychedelic Studies (MAPS), which is funding and leading the clinical trials.
1
The information offered here is not a substitute for professional advice. Please proceed with care and caution.
To continue customizing your FindCenter experience, create an account. It’s free!
Create an account to discover wisdom, save your favorite content, and connect with teachers and seekers.
IT’S FREE
If you already have an account, please log in.